Farryn Melton
About Farryn Melton
Farryn Melton is the Sr. Vice President and Chief Procurement Officer at Bristol Myers Squibb, with extensive experience in procurement and strategic sourcing across multiple industries.
Title
Farryn Melton holds the position of Sr. Vice President, Chief Procurement Officer at Bristol Myers Squibb in Princeton, New Jersey. In this role, she oversees the company’s procurement operations and strategies.
Professional Experience at Bristol Myers Squibb
As Sr. Vice President, Chief Procurement Officer at Bristol Myers Squibb, Farryn Melton oversees procurement strategies. Her work focuses on enterprise supply chain resiliency and delivering products to patients effectively. She has been instrumental in developing digital third-party risk management programs to enhance operational efficiency.
Previous Roles at Leading Companies
Farryn Melton has held significant leadership roles at several major corporations. She served as Vice President, Chief Procurement Officer at Amgen from 2005 to 2012, and as Vice President, Strategic Sourcing - North America CPO at Novartis from 2001 to 2005. Prior to these, she worked at Pfizer as Sr. Director Global Sourcing from 1999 to 2001, and at Warner Lambert as Director, Global Sourcing from 1997 to 1999, among other positions.
Leadership in Major Industry Mergers
Throughout her career, Farryn Melton played key roles in two of the largest healthcare integrations and a significant aerospace merger. These leadership positions enabled her to provide substantial accretive value to shareholders ahead of the projected timelines.
Mentoring and Non-Profit Engagement
Farryn Melton is actively involved in mentoring diverse leaders within and outside the healthcare industry. She holds executive roles in large non-profit organizations, including Historically Black Universities, arts & entertainment institutions, and minority NGOs, contributing her expertise and leadership capabilities to these organizations.
Innovations in Biologics, Cell, and Gene Therapy
Farryn Melton has extensive experience in novel modalities such as biologics and cell and gene therapy. This specialized knowledge has informed her procurement strategies and operational decisions, aligning them with emerging technologies and therapeutic modalities.
Diversity, Equity, and Inclusion Initiatives
During her career, Farryn Melton increased diverse spend by 100% over four years through actionable diversity, equity, and inclusion (DEI) strategies. Her commitment to DEI initiatives has contributed to fostering a more inclusive business environment.